Home> Products> sglt2 inhibitor and biguanide benefits

{ "products": [ { "_id": "68822dd35b399ba6097ed11b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET G 0.5 FORTE", "description": "SEIZMET G0.5 FORTE is a powerful oral antidiabetic medication formulated with a combination of glimepiride and metformin hydrochloride. This dual-action therapy is specifically designed for patients with type 2 diabetes mellitus who are unable to control their blood sugar levels with diet and exercise alone. The combination works in synergy to manage blood glucose effectively, reduce insulin resistance, and improve overall glycemic control.\n\nGlimepiride and metformin hydrochloride tablets are a combination medication used to treat type 2 diabetes. They work by helping the pancreas release more insulin and by reducing the amount of sugar produced by the liver, while also making the body more sensitive to insulin.\n\nWhat is SEIZMET G0.5 FORTE?\nSEIZMET G0.5 FORTE contains two active ingredients:\n\nGlimepiride (0.5 mg): A sulfonylurea class drug that stimulates the beta cells of the pancreas to release insulin.\n\nMetformin Hydrochloride: A biguanide that works primarily by suppressing hepatic glucose production and increasing insulin sensitivity in muscles.\n\nTogether, this combination addresses both insulin deficiency and resistance—two key factors in type 2 diabetes.\n\nUses of SEIZMET G0.5 FORTE:\n\nEffective in managing type 2 diabetes mellitus\n\nHelps in reducing fasting and postprandial blood glucose levels\n\nUsed as monotherapy or in combination with other antidiabetic agents\n\nReduces the risk of diabetic complications such as nephropathy, retinopathy, and cardiovascular disease\n\nSide Effects of SEIZMET G0.5 FORTE:\nLike all medications, glimepiride and metformin hydrochloride tablets may cause side effects in some patients. Common side effects include:\n\nNausea or vomiting\n\nDiarrhea\n\nHypoglycemia (low blood sugar)\n\nHeadache\n\nDizziness\n\nMetallic taste in the mouth\n\nAbdominal discomfort\n\nIn rare cases, it may cause lactic acidosis, a serious condition related to metformin accumulation.\n\nPrecautions Before Using SEIZMET G0.5 FORTE:\n\nAlways take the medication exactly as prescribed by your doctor.\n\nInform your physician if you have a history of liver or kidney disorders, heart disease, or alcohol abuse.\n\nAvoid excessive alcohol consumption while on this medication as it increases the risk of lactic acidosis.\n\nNot recommended for patients with type 1 diabetes or diabetic ketoacidosis.\n\nRegularly monitor your blood sugar and kidney function.\n\nThis medicine should be used during pregnancy only if absolutely necessary and under medical supervision.\n\nDrug Interactions: What Drugs Interact with SEIZMET G0.5 FORTE?\nCertain medications can interact with glimepiride and metformin, affecting their efficacy or increasing the risk of side effects. These include:\n\nBeta-blockers (e.g., propranolol) – may mask hypoglycemia symptoms\n\nDiuretics – may impair blood sugar control\n\nACE inhibitors – may increase the blood glucose-lowering effect\n\nCorticosteroids – may reduce the effectiveness of the medication\n\nAntipsychotics (e.g., olanzapine)\n\nAlcohol – increases the risk of lactic acidosis\n\nCimetidine – may raise metformin levels in the body\n\nAlways inform your healthcare provider about all medications, supplements, or herbal products you are taking.\n\nConclusion:\nSEIZMET G0.5 FORTE is a trusted, effective choice for managing type 2 diabetes, offering the combined benefits of glimepiride and metformin hydrochloride tablets. With dual mechanisms—enhancing insulin secretion and improving insulin sensitivity—it delivers comprehensive glycemic control. When taken as directed and with regular monitoring, SEIZMET G0.5 FORTE can be a valuable part of a diabetic patient’s treatment regimen, contributing to a healthier, more balanced life.\n\nFor best results, pair this medication with a proper diet, regular physical activity, and periodic blood glucose testing. Always consult your healthcare provider for personalized advice.", "price": 125.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2151, "imageuri": "https://productimages.withfloats.com/actual/68822dd8296c4d19d55e8535.png", "tileimageuri": "https://productimages.withfloats.com/tile/68822dd8296c4d19d55e8535.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-24T12:57:55.385Z", "updatedon": "2025-07-24T12:57:55.385Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-g-0-5-forte/2151", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "glimepiride and metformin hydrochloride tablets", "category": "DIABETIC RANGE", "tags": [ "glimepiride and metformin hydrochloride tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6810aa8d5a26e4010ea41a99", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH MET", "description": "EMPATECH MET 12.5/500 is a powerful oral antidiabetic combination therapy containing Empagliflozin and Metformin Hydrochloride, designed to manage Type 2 Diabetes Mellitus effectively. This dual-action formula helps control blood sugar levels, supports weight management, and offers added cardiovascular benefits. EMPATECH MET 12.5/500 is particularly beneficial for adults who require a second-line treatment when diet, exercise, and monotherapy are not sufficient.\n\nKey Ingredients\nEmpagliflozin (12.5 mg):\nA sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps reduce blood glucose levels by promoting glucose excretion through urine.\n\nMetformin Hydrochloride (500 mg):\nA biguanide class medication that lowers blood glucose by improving insulin sensitivity and reducing glucose production in the liver.\n\nKey Benefits\nHelps in lowering and maintaining stable blood glucose levels\n\nPromotes weight loss and reduces visceral fat\n\nReduces the risk of cardiovascular complications in diabetic patients\n\nSupports renal protection in people with diabetes and mild kidney dysfunction\n\nOffers a low risk of hypoglycemia compared to some other therapies\n\nImproves glycemic control with a dual mechanism of action\n\nHow Does It Work?\nEMPATECH MET 12.5/500 functions through two complementary mechanisms:\n\nEmpagliflozin works by blocking SGLT2 proteins in the kidneys, reducing the reabsorption of glucose and increasing its excretion via urine. This lowers blood sugar levels independently of insulin action.\n\nMetformin acts primarily by inhibiting hepatic glucose production and improving the body’s sensitivity to insulin, allowing for better uptake and usage of glucose by muscles and fat tissues.\n\nTogether, they provide a comprehensive glycemic control strategy, especially for patients not responding well to monotherapy.\n\nDirections for Use\nTake the tablet as prescribed by your doctor, usually once or twice daily with meals.\n\nSwallow the tablet whole with water; do not crush or chew.\n\nContinue following a healthy diet and regular exercise routine for optimal results.\n\nMonitor blood sugar levels regularly and report any unusual changes to your healthcare provider.\n\nDo not stop the medication without medical advice, even if your blood sugar levels improve.\n\nSide Effects\nCommon Side Effects:\n\nIncreased urination\n\nThirst or dry mouth\n\nNausea or mild gastrointestinal upset\n\nHeadache\n\nFatigue\n\nLess Common but Serious Side Effects:\n\nRisk of urinary tract infections or genital infections\n\nLactic acidosis (rare but serious; associated with Metformin)\n\nDehydration or low blood pressure, especially in elderly patients\n\nElectrolyte imbalances\n\nSeek immediate medical help if you experience severe abdominal pain, muscle cramping, breathing difficulties, or unusual tiredness.", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "unusual tiredness", "medical advice", "monotherapy directions", "healthcare provider", "healthy diet", "chew continue", "meals swallow", "fat tissues", "dual mechanism", "hypoglycemia compared", "cardiovascular complications", "secondline treatment", "metformin dehydration", "insulin allowing", "bodys sensitivity", "kidneys reducing", "low risk", "diet exercise", "improving insulin sensitivity", "promoting glucose excretion", "reducing glucose production", "side effects risk", "biguanide class medication", "lowers blood glucose", "low blood pressure", "regular exercise routine", "metformin hydrochloride designed", "urinary tract infections", "dry mouth nausea", "blocking sglt2 proteins" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2093, "imageuri": "https://productimages.withfloats.com/actual/6810aa8f5c4a4ba3d41a8c35.png", "tileimageuri": "https://productimages.withfloats.com/tile/6810aa8f5c4a4ba3d41a8c35.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-04-29T10:31:41.504Z", "updatedon": "2025-04-29T10:32:46.171Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-met/2093", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin (12.5mg) ,Metformin Hydrochloride (500mg)", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 12.5 mg+metformin 500 mg price", "empagliflozin 12.5 mg+metformin 1000 mg", "empagliflozin 12.5mg brands in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661ac5887f0960e14a2c914", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TENELIGOLD M 500 ", "description": "TENELIGOLD M 500 \nMetformin SR (500mg), Teneligliptin (20mg)\nTENELIGOLD M 500 is a combination medication containing Metformin Hydrochloride Sustained Release (SR) 500mg and Teneligliptin 20mg. It is primarily prescribed for the management of type 2 diabetes mellitus, a condition characterized by high blood sugar levels due to insulin resistance or inadequate insulin production.\n\nMetformin SR 500mg is a widely used oral antidiabetic medication that belongs to the biguanide class. It works by reducing the amount of glucose produced by the liver, increasing insulin sensitivity in muscle cells, and improving glucose uptake by tissues. This helps lower blood sugar levels and improves glycemic control.\n\nTeneligliptin 20mg is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It enhances insulin secretion from pancreatic beta cells and inhibits glucagon secretion, leading to reduced blood glucose levels after meals. By targeting different pathways in glucose metabolism, Teneligliptin complements the action of Metformin, resulting in better overall glycemic control.\n\nBenefits of TENELIGOLD M 500:\nComprehensive Glycemic Control: The combination of Metformin and Teneligliptin addresses both fasting and postprandial (after-meal) blood sugar levels, providing comprehensive glycemic control throughout the day.\n\nImproved Insulin Sensitivity: Metformin improves insulin sensitivity in cells, allowing better utilization of glucose and reducing insulin resistance.\n\nEnhanced Incretin Effect: Teneligliptin enhances the incretin effect, which regulates insulin secretion and glucagon levels, leading to better glucose regulation.\n\nWeight Management: Metformin is associated with weight neutrality or modest weight loss, making it beneficial for overweight or obese individuals with diabetes.\n\nLow Risk of Hypoglycemia: The risk of hypoglycemia (low blood sugar) with TENELIGOLD M 500 is low when used appropriately, making it a safer option for many patients.\n\nHow to Use TENELIGOLD M 500:\nDosage: The typical dosage is one tablet taken orally once or twice daily, as directed by your healthcare provider. Dosage adjustments may be made based on blood sugar levels and individual response.\n\nAdministration: Take the tablet with meals to reduce gastrointestinal side effects and enhance absorption. Swallow it whole with a glass of water, and do not crush or chew the tablet unless advised otherwise.\n\nSafety Considerations:\nMedical History: Inform your doctor about any medical conditions you have, especially kidney or liver problems, as well as any medications or supplements you are taking.\n\nPregnancy and Nursing: Discuss the risks and benefits of TENELIGOLD M 500 if you are pregnant, planning pregnancy, or breastfeeding.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/teneligold-m-500-133449", "price": 122.75, "discountamount": 36.83, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "Order", "meals", "glass", "risks", "water", "EMAIL", "action", "option", "amount", "kidney", "doctor", "fasting", "reduced", "tissues", "Nursing", "Low Risk", "Benefits", "Pregnancy", "absorption", "overweight", "one tablet", "medications", "supplements", "utilization", "information", "TENELIGOLD M", "Hypoglycemia", "muscle cells", "sterispharma", "postprandial", "sterisonline", "many patients", "breastfeeding", "CALL/WHATSAPP", "typical dosage", "Administration", "liver problems", "glucose uptake", "low blood sugar", "Medical History", "glucagon levels", "biguanide class", "DPP-4) inhibitor", "Weight Management", "weight neutrality", "obese individuals", "insulin secretion", "glucose regulation", "modest weight loss", "Metformin SR 500mg", "glucose metabolism", "insulin resistance", "glucagon secretion", "different pathways", "Teneligliptin 20mg", "Dosage adjustments", "medical conditions", "insulin sensitivity", "healthcare provider", "individual response", "blood glucose levels", "Safety Considerations", "pancreatic beta cells", "combination medication", "dipeptidyl peptidase-4", "high blood sugar levels", "overall glycemic control", "Enhanced Incretin Effect", "meal) blood sugar levels", "type 2 diabetes mellitus", "oral antidiabetic medication", "gastrointestinal side effects", "inadequate insulin production", "Comprehensive Glycemic Control", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1479, "imageuri": "https://productimages.withfloats.com/actual/6661ac5c4b296a211c2d34ee.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661ac5c4b296a211c2d34ee.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:32:24.912Z", "updatedon": "2024-06-29T05:26:50.914Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/teneligold-m-500-/1479", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TENELIGOLD M 500 ", "category": "DIABETIC RANGE", "tags": [ "TENELIGOLD M 500", "Metformin SR (500mg)", "Teneligliptin (20mg)", "Teneligliptin Tablets 20 mg uses", "Teneligliptin 20 mg price", "Teneligliptin 20 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666159468da3a81d5c6a08d8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD M 500 ", "description": "PAFAGOLD M 500 \nDapaflozin 10 mg + Metformin SR 500 mg\nIntroduction to PAFAGOLD M 500\nPAFAGOLD M 500 is a combination medication that includes Dapagliflozin 10mg and Metformin Hydrochloride Sustained Release (SR) 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, PAFAGOLD M 500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This helps lower blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of PAFAGOLD M 500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps regulate fasting glucose levels by promoting glucose excretion through urine, while Metformin assists in lowering both fasting and postprandial (after-meal) glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD M 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD M 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD M 500\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD M 500 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD M 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-m-500-134322", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "Diet", "body", "Order", "liver", "EMAIL", "urine", "meals", "water", "action", "amount", "kidneys", "Support", "Overview", "readings", "calories", "biguanide", "one tablet", "full glass", "neuropathy", "Dapaflozin", "PAFAGOLD M", "Guidelines", "weight loss", "information", "Optimal Use", "Adjustments", "utilization", "retinopathy", "Introduction", "Reduced Risk", "Metformin SR", "best results", "sterisonline", "Postprandial", "sterispharma", "heart failure", "CALL/WHATSAPP", "effectiveness", "Consistent Use", "treatment plan", "sodium-glucose", "Administration", "dual mechanism", "typical dosage", "two medications", "prolonged effect", "Exercise Adjunct", "SGLT2 inhibitors", "excellent adjunct", "glucose excretion", "Weight Management", "diabetic patients", "multiple pathways", "glucose regulation", "Recommended Dosage", "Dapagliflozin 10mg", "additional benefits", "insulin sensitivity", "blood sugar control", "healthcare provider", "Diabetes Management", "individual response", "meal) glucose levels", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "cardiovascular benefits", "type 2 diabetes mellitus", "transporter-2) inhibitor", "complementary mechanisms", "cardiovascular protection", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "hepatic glucose production", "gastrointestinal discomfort", "other cardiovascular events", "sustained-release formulation", "comprehensive glycemic control", "Effective Blood Sugar Management", "comprehensive blood sugar management", "Metformin Hydrochloride Sustained Release" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1405, "imageuri": "https://productimages.withfloats.com/actual/666159486030c166b1a8a9f2.png", "tileimageuri": "https://productimages.withfloats.com/tile/666159486030c166b1a8a9f2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T06:37:58.426Z", "updatedon": "2024-06-29T10:36:59.351Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//pafagold-m-500-/1405", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD M 500 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD M 500", "Dapaflozin 10 mg", "Metformin SR 500 mg", "Dapagliflozin 10 mg dosage", "Dapagliflozin 10 mg price", "Dapagliflozin 10 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6660561aea22b014e8af1a73", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAFAGOLD M 1000 ", "description": "PAFAGOLD M 1000 \nDapagliflozin , Metformin Hydrochloride\nIntroduction to PAFAGOLD M 1000\nPAFAGOLD M 1000 is a combination medication that includes Dapagliflozin and Metformin Hydrochloride. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, PAFAGOLD M 1000 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood, which allows glucose to be excreted in the urine. This helps lower blood sugar levels. Dapagliflozin also offers additional benefits such as weight loss and cardiovascular protection.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of PAFAGOLD M 1000\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps regulate fasting glucose levels by promoting glucose excretion through urine, while Metformin assists in lowering both fasting and postprandial (after-meal) glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PAFAGOLD M 1000 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PAFAGOLD M 1000 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nHow to Use PAFAGOLD M 1000\nDosage and Administration\nRecommended Dosage: The typical dosage of PAFAGOLD M 1000 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PAFAGOLD M 1000 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/pafagold-m-1000-134127", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Diet", "body", "liver", "EMAIL", "urine", "Order", "meals", "water", "amount", "action", "kidneys", "Support", "Overview", "readings", "calories", "biguanide", "full glass", "Guidelines", "neuropathy", "PAFAGOLD M", "one tablet", "weight loss", "Optimal Use", "retinopathy", "information", "utilization", "Adjustments", "Introduction", "sterispharma", "best results", "Reduced Risk", "sterisonline", "Postprandial", "effectiveness", "heart failure", "CALL/WHATSAPP", "Dapagliflozin", "treatment plan", "Consistent Use", "sodium-glucose", "Administration", "dual mechanism", "typical dosage", "two medications", "SGLT2 inhibitors", "Exercise Adjunct", "multiple pathways", "excellent adjunct", "Weight Management", "diabetic patients", "glucose excretion", "Recommended Dosage", "glucose regulation", "Diabetes Management", "additional benefits", "blood sugar control", "insulin sensitivity", "healthcare provider", "individual response", "meal) glucose levels", "cardiovascular disease", "combination medication", "long-term complications", "lifestyle modifications", "cardiovascular benefits", "Fasting Glucose Control", "Metformin Hydrochloride", "type 2 diabetes mellitus", "transporter-2) inhibitor", "complementary mechanisms", "peripheral glucose uptake", "stable blood sugar levels", "cardiovascular protection", "hepatic glucose production", "Additional Health Benefits", "other cardiovascular events", "gastrointestinal discomfort", "comprehensive glycemic control", "Effective Blood Sugar Management", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1391, "imageuri": "https://productimages.withfloats.com/actual/6660561dc40ee9be0199735b.png", "tileimageuri": "https://productimages.withfloats.com/tile/6660561dc40ee9be0199735b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T12:12:10.69Z", "updatedon": "2024-06-29T11:03:11.406Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pafagold-m-1000-/1391", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAFAGOLD M 1000 ", "category": "DIABETIC RANGE", "tags": [ "PAFAGOLD M 1000", "Dapagliflozin", "Metformin Hydrochloride", "Metformin hydrochloride uses", "Metformin hydrochloride side effects", "Metformin hydrochloride 1000 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666050a6ea22b014e8af196f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LINALIGLIP M 5/500 ", "description": "LINALIGLIP M 5/500 \nLinagliptin 5mg and Metformin Hydrochloride (SR) 500mg\nIntroduction to LINALIGLIP M 5/500\nLINALIGLIP M 5/500 is a combination medication that includes Linagliptin 5mg and Metformin Hydrochloride (Sustained Release) 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Linagliptin and Metformin, LINALIGLIP M 5/500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Linagliptin and Metformin?\nOverview of Linagliptin\nLinagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that helps regulate blood glucose levels by increasing insulin release and decreasing glucagon levels in response to meals. By enhancing incretin hormones, Linagliptin aids in maintaining better overall blood sugar control throughout the day.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release (SR) formulation ensures a prolonged effect throughout the day.\n\nBenefits of LINALIGLIP M 5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Linagliptin helps regulate postprandial (after-meal) glucose levels, while Metformin assists in lowering fasting glucose levels by promoting insulin sensitivity and reducing hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: LINALIGLIP M 5/500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, LINALIGLIP M 5/500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is known to have a neutral or weight-reducing effect, making it beneficial for patients concerned about weight gain.\nCardiovascular Protection: The combination may offer additional cardiovascular benefits by improving overall metabolic health.\nConvenience and Compliance\nTwice-Daily Dosing: The sustained-release formulation of Metformin allows for effective blood sugar control with twice-daily dosing, improving patient compliance and convenience.\nReduced Pill Burden: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use LINALIGLIP M 5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of LINALIGLIP M 5/500 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take LINALIGLIP M 5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/linaliglip-m-5-500-134301", "price": 245.0, "discountamount": 73.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "body", "Diet", "Order", "EMAIL", "liver", "meals", "water", "amount", "action", "neutral", "Support", "Overview", "patients", "one pill", "readings", "biguanide", "Guidelines", "full glass", "one tablet", "neuropathy", "Optimal Use", "utilization", "retinopathy", "Convenience", "Adjustments", "information", "weight gain", "Introduction", "Reduced Risk", "best results", "sterispharma", "Postprandial", "sterisonline", "CALL/WHATSAPP", "effectiveness", "typical dosage", "dual mechanism", "Administration", "treatment plan", "Consistent Use", "insulin release", "Linagliptin 5mg", "glucagon levels", "two medications", "prolonged effect", "Exercise Adjunct", "incretin hormones", "Weight Management", "Sustained Release", "treatment regimen", "excellent adjunct", "multiple pathways", "LINALIGLIP M 5/500", "glucose regulation", "patient compliance", "Twice-Daily Dosing", "Recommended Dosage", "prescribed therapy", "individual response", "insulin sensitivity", "Reduced Pill Burden", "Diabetes Management", "healthcare provider", "meal) glucose levels", "blood glucose levels", "cardiovascular disease", "combination medication", "weight-reducing effect", "Fasting Glucose Control", "lifestyle modifications", "Metformin Hydrochloride", "long-term complications", "complementary mechanisms", "type 2 diabetes mellitus", "overall metabolic health", "Cardiovascular Protection", "peripheral glucose uptake", "stable blood sugar levels", "Additional Health Benefits", "hepatic glucose production", "overall blood sugar control", "gastrointestinal discomfort", "sustained-release formulation", "effective blood sugar control", "comprehensive glycemic control", "Effective Blood Sugar Management", "dipeptidyl peptidase-4) inhibitor", "additional cardiovascular benefits", "sustained-release (SR) formulation", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1384, "imageuri": "https://productimages.withfloats.com/actual/666050a84f159c14e162c5d7.png", "tileimageuri": "https://productimages.withfloats.com/tile/666050a84f159c14e162c5d7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:48:54.497Z", "updatedon": "2024-06-29T11:16:30.61Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/linaliglip-m-5-500-/1384", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGLIP M 5/500 ", "category": "DIABETIC RANGE", "tags": [ "LINALIGLIP M 5/500", "Linagliptin 5mg", "Metformin Hydrochloride (SR) 500mg", "Metformin hydrochloride SR 500 mg uses", "Metformin SR 500 side effects", "Metformin SR 500 dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666036ade5c8fb18fc193640", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 5/500 ", "description": "GLIDAPAFLOZIN M 5/500 \nDapagliflozin (5mg), Metformin (500mg)\nIntroduction to GLIDAPAFLOZIN M 5/500\nGLIDAPAFLOZIN M 5/500 is a combination medication that includes Dapagliflozin 5mg and Metformin 500mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Dapagliflozin and Metformin, GLIDAPAFLOZIN M 5/500 provides comprehensive glycemic control, helping patients achieve better blood sugar management and overall metabolic health.\n\nWhat are Dapagliflozin and Metformin?\nOverview of Dapagliflozin\nDapagliflozin is an SGLT2 (sodium-glucose co-transporter-2) inhibitor that works by preventing the kidneys from reabsorbing glucose back into the blood. Instead, it allows glucose to be excreted in the urine, thereby lowering blood glucose levels.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization.\n\nBenefits of GLIDAPAFLOZIN M 5/500\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: Dapagliflozin helps reduce both postprandial (after-meal) and fasting blood glucose levels by promoting glucose excretion through urine.\nBasal Glucose Control: Metformin helps maintain lower fasting blood sugar levels by improving insulin sensitivity and decreasing hepatic glucose production.\nWeight Management and Cardiovascular Benefits\nWeight Reduction: Dapagliflozin has been associated with weight loss due to the excretion of glucose and calories in the urine.\nCardiovascular Protection: SGLT2 inhibitors like Dapagliflozin have been shown to provide cardiovascular benefits, reducing the risk of heart failure and other cardiovascular events in diabetic patients.\nComprehensive Diabetes Management\nDual Mechanism: The combination of Dapagliflozin and Metformin offers a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nConvenience and Compliance: Combining two effective diabetes medications into one pill simplifies the treatment regimen, making it easier for patients to adhere to their prescribed therapy.\nHow to Use GLIDAPAFLOZIN M 5/500\nDosage and Administration\nRecommended Dosage: The typical dosage of GLIDAPAFLOZIN M 5/500 is one tablet taken twice daily, usually with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take GLIDAPAFLOZIN M 5/500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-5-500-133424", "price": 128.79, "discountamount": 38.63, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "meal", "risk", "water", "EMAIL", "liver", "Order", "urine", "amount", "action", "therapy", "kidneys", "readings", "one pill", "Overview", "calories", "Metformin", "biguanide", "full glass", "Guidelines", "one tablet", "Compliance", "utilization", "weight loss", "Adjustments", "information", "Optimal Use", "Convenience", "sterisonline", "Introduction", "sterispharma", "Postprandial", "best results", "heart failure", "effectiveness", "CALL/WHATSAPP", "Dapagliflozin", "Consistent Use", "sodium-glucose", "Dual Mechanism", "Administration", "typical dosage", "treatment plan", "GLIDAPAFLOZIN M", "SGLT2 inhibitors", "Weight Reduction", "Weight Management", "diabetic patients", "glucose excretion", "multiple pathways", "treatment regimen", "Recommended Dosage", "blood sugar levels", "glucose regulation", "insulin sensitivity", "individual response", "healthcare provider", "blood glucose levels", "Basal Glucose Control", "combination medication", "Fasting Glucose Control", "Cardiovascular Benefits", "transporter-2) inhibitor", "complementary mechanisms", "type 2 diabetes mellitus", "overall metabolic health", "Cardiovascular Protection", "peripheral glucose uptake", "hepatic glucose production", "gastrointestinal discomfort", "other cardiovascular events", "comprehensive glycemic control", "Effective Blood Sugar Management", "Comprehensive Diabetes Management", "two effective diabetes medications", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1359, "imageuri": "https://productimages.withfloats.com/actual/666036b0487c46164ce21532.png", "tileimageuri": "https://productimages.withfloats.com/tile/666036b0487c46164ce21532.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T09:58:05.188Z", "updatedon": "2024-06-29T12:36:58.891Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-m-5-500-/1359", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 5/500 ", "category": "DIABETIC RANGE", "tags": [ "GLIDAPAFLOZIN M 5/500", "Dapagliflozin (5mg)", "Metformin (500mg)", "Dapagliflozin 5mg uses", "Dapagliflozin 5 mg uses", "Dapagliflozin 5 mg dosage", "Dapagliflozin 5 mg heart failure" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68949d4ea0059029dc8c8915", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BENZTETRA 25", "description": "BENZTETRA 25 contains the active ingredient tetrabenazine 25mg, a specialized medication used primarily to manage involuntary movements associated with neurological disorders. Tetrabenazine is classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor and works by regulating the levels of neurotransmitters such as dopamine, serotonin, norepinephrine, and histamine in the brain. This correction of chemical imbalances helps reduce excessive and uncontrolled muscle movements. BENZTETRA 25 is especially valuable for patients suffering from movement disorders that significantly impact their daily functioning. It helps improve motor control, thereby enhancing quality of life for those affected. This medication is prescribed mainly to treat chorea—a movement disorder characterized by jerky, irregular, and uncontrollable muscle movements—that is caused by Huntington disease.\n\nWhat is BENZTETRA 25?\nBENZTETRA 25 is a therapeutic tablet containing tetrabenazine 25mg, designed to treat involuntary movements (chorea) linked to Huntington disease. It does not cure Huntington disease nor address cognitive or psychiatric symptoms of the disease but effectively reduces the severity of abnormal movements by altering neurotransmitter activity in the brain.\n\nUses of BENZTETRA 25\n\nTo treat chorea (a movement disorder) that is caused by Huntington disease.\n\nTo control involuntary muscle movements in Huntington’s disease patients.\n\nManagement of other hyperkinetic movement disorders as determined by a healthcare provider (such as tardive dyskinesia or Tourette syndrome in some cases).\n\nTo reduce excessive motor activity caused by abnormal nerve signaling in the brain, improving voluntary muscle control.\n\nSide Effects of BENZTETRA 25\n\nDrowsiness and fatigue, which may affect alertness.\n\nInsomnia or difficulty sleeping.\n\nNausea, vomiting, or abdominal discomfort.\n\nParkinsonism symptoms such as tremors, muscle rigidity, and slowed movements (bradykinesia).\n\nMood alterations including depression, anxiety, and in severe cases, suicidal thoughts.\n\nRare serious reactions like allergic responses, heart rhythm irregularities, or neuroleptic malignant syndrome (characterized by high fever, muscle stiffness).\n\nPrecautions Before Using BENZTETRA 25\n\nInform your doctor if you have a history of depression, suicidal thoughts, or any psychiatric illness.\n\nAvoid use if you have severe liver disease or have recently taken monoamine oxidase inhibitors (MAOIs).\n\nCaution in patients with cardiac issues due to potential QT interval prolongation.\n\nUse with care when driving or operating machinery as BENZTETRA 25 may cause dizziness or drowsiness.\n\nDo not stop the medication suddenly without consulting your healthcare provider, as symptoms might worsen.\n\nRegular monitoring by a healthcare professional is recommended to assess side effects and efficacy.\n\nDrug Interactions: What Drugs Interact with BENZTETRA 25?\n\nMAO inhibitors such as isocarboxazid, phenelzine, selegiline, and others can cause dangerous interactions and should not be used concurrently.\n\nOther drugs that affect serotonin levels, including selective serotonin reuptake inhibitors (SSRIs), may increase the risk of serotonin syndrome.\n\nCaution with other medications known to prolong the QT interval or those affecting dopamine systems.\n\nInteractions with neuroleptics or antipsychotics require close medical supervision due to additive effects on movement and mood.\n\nConclusion\nBENZTETRA 25, containing tetrabenazine 25mg, is a vital medication for managing chorea associated with Huntington disease by modulating neurotransmitter levels in the brain to reduce involuntary movements. While it offers substantial benefits in improving motor control, careful attention to side effects, precautions, and drug interactions is essential for safe and effective use. Always follow the guidance of a healthcare professional when using BENZTETRA 25 to ensure optimal outcomes and safety.", "price": 425.0, "discountamount": 128.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2158, "imageuri": "https://productimages.withfloats.com/actual/68949d54c82f93461bdc841f.png", "tileimageuri": "https://productimages.withfloats.com/tile/68949d54c82f93461bdc841f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-07T12:34:22.411Z", "updatedon": "2025-08-07T12:34:22.411Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/benztetra-25/2158", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "tetrabenazine 25mg", "category": "NEUROLOGY RANGE", "tags": [ "tetrabenazine 25mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "686e5df44c01bda1661052f0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ALFUGEM T 2.5/10", "description": "ALFUGEM T 2.5/10 is a scientifically formulated dual-action oral tablet that combines Alfuzosin 2.5 mg and Tadalafil 10 mg. This unique combination is primarily used for the treatment of benign prostatic hyperplasia (BPH) and erectile dysfunction (ED) in men. By blending a selective alpha-blocker (Alfuzosin) with a phosphodiesterase-5 (PDE5) inhibitor (Tadalafil), ALFUGEM T 2.5/10 offers an effective solution for patients who suffer from both urological conditions.\n\nThe combination of alfuzosin and tadalafil has been shown to have an additive relaxant effect on human detrusor and prostatic tissues in vitro, enhancing urinary flow and improving sexual function.\n\nWhat is ALFUGEM T 2.5/10?\nALFUGEM T 2.5/10 is a fixed-dose combination tablet that contains two active ingredients:\n\nAlfuzosin (2.5 mg) – an alpha-1 adrenergic receptor blocker that relaxes the muscles in the prostate and bladder neck.\n\nTadalafil (10 mg) – a PDE5 inhibitor that increases blood flow to the penis and also helps relax the smooth muscles in the prostate and bladder.\n\nTogether, they help relieve lower urinary tract symptoms (LUTS) associated with BPH and improve erectile function in men.\n\nUses of ALFUGEM T 2.5/10:\nTreatment of Benign Prostatic Hyperplasia (BPH)\n\nRelief of lower urinary tract symptoms (LUTS) such as weak stream, urgency, and incomplete bladder emptying\n\nManagement of erectile dysfunction (ED) in men\n\nMay be beneficial for patients with both BPH and ED as a once-daily treatment\n\nHow Does ALFUGEM T 2.5/10 Work?\nAlfuzosin works by blocking alpha-1 receptors in the prostate and bladder, leading to relaxation of smooth muscle and improved urine flow.\n\nTadalafil enhances nitric oxide activity, leading to vasodilation in the penile tissues and also relaxes the lower urinary tract muscles.\n\nThe additive relaxant effect of this combination on the prostate and bladder tissues helps improve both urinary and sexual symptoms.\n\nSide Effects of ALFUGEM T 2.5/10:\nLike all medications, ALFUGEM T 2.5/10 may cause some side effects. Common side effects include:\n\nDizziness or lightheadedness\n\nHeadache\n\nBack pain or muscle aches\n\nNasal congestion\n\nIndigestion\n\nFlushing\n\nLow blood pressure (hypotension) in some cases\n\nRare but serious side effects may include:\n\nFainting or severe dizziness\n\nPriapism (prolonged or painful erection)\n\nVision changes or sudden vision loss\n\nChest pain or irregular heartbeat\n\nPrecautions Before Using ALFUGEM T 2.5/10:\nConsult your doctor before use if you have a history of heart disease, liver/kidney problems, or hypotension.\n\nAvoid activities like driving or operating machinery if you feel dizzy after taking the tablet.\n\nDo not take with other PDE5 inhibitors or alpha-blockers unless prescribed.\n\nLimit alcohol intake, as it can increase the risk of dizziness or low blood pressure.\n\nNot recommended for use in women or children.\n\nDrug Interactions – What Drugs Interact with ALFUGEM T 2.5/10?\nCertain drugs may interact with ALFUGEM T 2.5/10 and affect its effectiveness or increase the risk of side effects:\n\nAvoid or use with caution:\n\nNitrates (e.g., nitroglycerin) – can cause dangerous drops in blood pressure\n\nOther alpha-blockers – increased risk of hypotension\n\nAntifungals (e.g., ketoconazole, itraconazole)\n\nHIV protease inhibitors (e.g., ritonavir)\n\nAntibiotics (e.g., erythromycin, clarithromycin)\n\nBlood pressure medications – may enhance hypotensive effect\n\nGrapefruit juice – can alter the drug metabolism\n\nAlways inform your doctor about all the medications and supplements you are taking.\n\nConclusion:\nALFUGEM T 2.5/10 offers a comprehensive dual-action approach to managing two common male conditions – BPH and ED. With the clinically proven benefits of alfuzosin and tadalafil, this medication not only improves urinary flow and relieves prostate-related discomfort but also enhances sexual performance. Its synergistic relaxant effect on the bladder, prostate, and penile tissues makes it an ideal solution for men looking for convenience, efficacy, and improved quality of life.\n\nAlways follow your healthcare provider’s instructions for safe and effective use.", "price": 310.0, "discountamount": 93.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2143, "imageuri": "https://productimages.withfloats.com/actual/686e5df9e9241987c803df61.png", "tileimageuri": "https://productimages.withfloats.com/tile/686e5df9e9241987c803df61.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-09T12:17:56.999Z", "updatedon": "2025-07-09T12:17:56.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/alfugem-t-2-5-10/2143", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "alfuzosin and tadalafil", "category": "UROLOGYRANGE", "tags": [ "alfuzosin and tadalafil" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }